Crossmark

Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes

Crossref DOI link: https://doi.org/10.1007/s12020-019-01871-7

Published Online: 2019-02-25

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peiró, Inmaculada https://orcid.org/0000-0003-2136-3866
Palmero, Ramón

Iglesias, Pedro

Díez, Juan José

Simó-Servat, Andreu

Marín, Juan Antonio

Jiménez, Laura

Domingo-Domenech, Eva

Mancho-Fora, Nuria

Nadal, Ernest

Villabona, Carlos
License Information

Text and Data Mining valid from 2019-02-25
More Information

Article History

Received: 8 October 2018

Accepted: 12 February 2019

First Online: 25 February 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.